Highlights from Cleveland Clinic 10th Annual Obesity Summit: A Decade of Progress
Read more here.
The Kardashian index: a measure of discrepant social media profile for scientists
Read more here.
The United Health Foundation released the 25th annual America's Health Rankings
The United Health Foundation released the 25th annual America's Health Rankings today. Ohio ranks 40th - a score that leaves us with lots of room for improvement. Nationally, the annual report found that adult diabetes rates were up, now at 10%, while obesity rates also increased - from 27.6% in 2013, to 29.4% this year. Americans are also less active, with 23.5 percent of adults reporting no physical activity in the previous 30 days compared to 22.9 percent in 2013. On the plus side, national smoking rates fell by 3 percent in 2014.
Read more here: http://www.americashealthrankings.org/reports/Annual
NEW Biosketch Format for NIH Grant Applications
Beginning January 25, 2015 – the new NIH Biosketch format allows researchers to describe how their background and expertise relates to their proposed project. The new format is described in a guide notice published at the following link: (NOT-OD-15-024). The new format is available in the “additional format pages” section of the SF424 applications page.
The SF424 applications page also includes a link to the Science Experts Network Curriculum Vitae (SciENcv). This system allows you to enter your biographical data once and convert it into biosketches that can be used with both NIH or NSF grant applications and annual progress reports. If you have already built your biosketch in SciENcv, you will be able to adapt your existing information into the new modified format. A video providing instructions for using SciENcv is available on the National Center for Biotechnology Innovation (NCBI) YouTube channel.
Tool Predicts Sleeve Gastrectomy Risk
Published: Nov 9, 2014
BOSTON - A new risk calculator may help clinicians better select which patients are candidates for sleeve gastrectomy, researchers reported here read more .
Congratulations to Dr. Takhar Kasumov for receiving an innovation award from the American Diabetes Association's Research Program.
"Lipoproteome Dynamics as a Novel Approach for the Assessment of HDL Functionality in Patients with Type 2 Diabetes in Vivo.,"
October 2, 2014
Congratulations to Dr. Kashyap for receiving a sub-award for a NIDDK U01 grant.
August 27, 2014
Vitamin D for Type 2 Diabetes Prevention
The D2d study is a multicenter, randomized (1:1), double-masked, placebo-controlled, parallel-group primary prevention clinical trial with 2 arms (oral daily vitamin D3 vs placebo) in participants at high risk for diabetes (with pre-diabetes) who will be followed for approximately 4 years after randomization for incident diabetes.
Adults at increased risk for type 2 diabetes (pre-diabetes), defined as meeting two-out-of-three ADA glycemic criteria established in 2010 (FPG 100-125 mg/dL or 2hPG 140-199 mg/dL or HbA1c 5.7-6.4%), will be randomized to receive, once daily, either a single soft-gel of vitamin D3 (cholecalciferol, 4000 IU) or matching placebo. Study participants will be seen every 3 months during the first 6 months and every 6 months for the remainder of the study. At the midpoint of each 6-month after the month 6 visit, participants will receive a telephone call to encourage compliance, assess for adverse events and receive a reminder of their upcoming visit. The primary outcome will be time to diabetes, defined by laboratory criteria derived from a 75-gram OGTT [to obtain 2hPG] done annually, FPG and HbA1c done every 6 months or when symptoms consistent with hyperglycemia are reported.
An Announcement from Case Western Reserve University Office of Research Administration
June 24, 2014
Nutrition Obesity Research Center (NORC)
NIH Has just reissued RFA DK-12-004 soliciting applications for P30 Nutrition Obesity Research Centers (NORCs) with a due date of November 25, 2014. The Center for Science, Health and Society is planning to resubmit an application for this opportunity encompassing all CWRU associated institutions, including the School of Medicine, Cleveland Clinic and the Lerner College of Medicine, any other interested CWRU Schools, University Hospitals Case Medical Center, MetroHealth Medical Center and the Louis Stokes VA Medical Center.
Leadership for this initiative is being provided by Nate Berger, CWRU, Patrick Catalano, MetroHealth and John Kirwan, Cleveland Clinic. At this time, in order to guide the center in framing the application, interested faculty members are invited to send a description (no more than one page) of their research and/or clinical activities relevant to nutrition, obesity, weight loss, exercise, bariatric surgery, energy metabolism, lipids, body composition, adipose tissue, inflammation, non alcoholic fatty liver disease, etc.
Please include a list of any current and/or pending support of these activities.
All materials should be sent to Lian Yang, (firstname.lastname@example.org) by June 30, 2014.
Monday's On the Scene Hallway Buzz interviews
March 31, 2014
WASHINGTON -- Monday's On the Scene Hallway Buzz interviews: Deepak Bhatt, MD and co-PI Sangeeta Kashyap, MD on STAMPEDE; Jeffrey S. Berger, MD and Elliott Antman, MD on POISE-2; Howard Weintraub, MD on GIPS III; and more on MSC-HF and HEAT-PPCI. read more
Dr. Stacy Brethauer in MedPage Today "Diabetes 'Cure' After Weight Loss Surgery Lasts Long Term"
Tuesday April 9, 2013
Congratulations to our Cleveland Clinic Endocrinology & Metaboliam Institute staff who were named "Best Doctors" in Cleveland Magazine’s March issue!
- Endocinology & Metabolism
Dr. Amir Hamrahian, Dr. Betul Hatiploglu, Dr. Laurence Kennedy, Dr. Cecilia Lansang, Dr. Angelo Licata, Dr. Adi Mehta, and Dr. Robert Zimmerman
Dr. Philip R. Schauer and Dr. Allan Siperstein
STAMPEDE Sub-study paper by Dr. Sangeeta Kashyap and colleagues "Metabolic Effects of Bariatric Surgery in Patients with Moderate Obesity and Type 2 Diabetes: Analysis of a randomized Control Trial Comparing Surgery vs. Intensive Medical Treatment." Published in Diabetes Care Journal.
Tuesday February, 26 2013
- Media involving this trial
Anny Mulya, PhD, wins First Place in Clinical Science in the 2012 Cleveland Clinic-wide Merlin Bumpus Junior Investigator Awards
November 1, 2012
- The F. Merlin Bumpus Junior Investigator Award was created in his honor to highlight excellence in research by graduate students and postdoctoral fellows in basic and clinical areas. Anny Mulya, PhD, won first place in Clinical Science for her study "Unpregulation of Pgc-1a and Fat Transpo *Rt/Oxidation Genes in Muscle is Linked to Improved Insulin Sensitivity Following a Lifestyle Intervention."